Abstract Detail

Abstract

Triple negative breast cancer (TNBC) is considered as an aggressive sub group of breast cancer and the incidence are increasing.  Neo adjuvant chemotherapy is recommended in TNBC, if ≥cT2 or ≥cN1. Clinical prognostication and postoperative decision-making rely exclusively on whether a pathologic complete response (pCR) is achieved or not. Recent studies confirm the addition of immunotherapy in neo adjuvant protocol achieve a better rate of complete pathological response. The protocol of pretreatment evaluation (mapping, marking of tumour and axilla) requires not only expertise but advanced equipment. Moreover, neo adjuvant therapy and frequent response evaluation of disease adds extra financial and psychological pressure on the patients. 
Treating patients in tier three city with limited resources and financial constraint is a challenging task. 50 TNBC patients with follow up of more than 4years were analysed retrospectively. All these patients were treated with upfront surgery and adjuvant therapy. The results were evaluated on the basis of disease free survival and recurrence. The results were found to be comparable.

Biography

Dr Manmohan Agrawal (Consultant Oncosurgeon) MBBS MS, DNB Surgical. Oncology is working as surgical oncologist in Department of Oncosurgery, Pushpadi cancer care centre, Kota, Rajasthan,India. Dr. Manmohan has obtained his Master of surgery degree from SCB medical College, Utkal University in 2005 and completed his DNB from Dharamshila Cancer hospital, Delhi in 2009. He has more than 10 years of experience in the field of cancer surgery and had performed more than 5000 cancer surgeries. Being in a tyre III city like Kota with limited resources, he has learnt to provide adequate cancer care at a grassroots level. He has done many complicated and difficult surgeries independently like 3 field esophagectomy (25 cases), Whipples procedure (50 cases), pelvic exenteration (10 cases), Breast (>1000 surgery). His main researches are focused on head and neck cancer, breast cancer and gynaecological malignancy. He has published many articles in national and international journals.